Submitted by: Submitted by HexaReport
Views: 10
Words: 828
Pages: 4
Category: Business and Industry
Date Submitted: 06/01/2016 11:07 PM
Hexa Reports
Market Research Reports and Insightful Company Profiles
Pre-Diabetes/Impaired Glucose Tolerance Market Share,
Trends, Size, Growth, Regulations, and Competitive
Landscape, Global Clinical Trials Review, H1, 2016
Summary
GlobalData's clinical trial report, "Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review,
H1, 2016" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This
report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance.
Report includes an overview of trial numbers and their average enrollment in top countries conducted
across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end
points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials).
Browse Detail Report With TOC @ http://www.hexareports.com/report/pre-diabetes-impairedglucose-tolerance-global-clinical-trials-review-h1-2016/details
GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack
Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences,
journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic
process.
Hexa Reports
Market Research Reports and Insightful Company Profiles
The report enhances the decision making capabilities and helps to create an effective counter strategies
to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance
of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial
Status, Trial Phase, Sponsor Type and End point status
The report reviews top...